FibroBiologics, Inc.

FBLG
$0.95 (+ $0.02 + 2.57%)
Last updated: 2026-06-10 21:12 UTC
FBLG Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS31573L2043
CUSIP31573L204
Market Price0.95
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.48
Market Cap$15.7M
Book Value0.0
Price to Book78.633
BetaN/A
52w High2.43
52w Low0.22
Next Earnings DateN/A

FibroBiologics, Inc. trades under ticker FBLG on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US31573L2043, CUSIP 31573L204.

About the Company
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications. The company was founded in 2021 and is based in Houston, Texas.
Price History